Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomised Trial to Evaluate the Role of Paclitaxel Eluting Stent and Tirofiban to Improve the Results of Facilitated PCI in the Treatment of Acute ST- Segment Elevation Myocardial Infarction
Brief Summary: The conceptual hypothesis of this study is that, in patients with acute myocardial infarction and ST-segment elevation, the strategy of performing coronary angioplasty of the culprit artery with paclitaxel eluting stent significantly reduces the rate of restenosis in comparison with bare stents.

The conceptual hypothesis of this study is that, in patients with acute myocardial infarction and ST-segment elevation, the strategy of performing coronary stent-angioplasty of the culprit artery under the protection of tirofiban 120 minutes after fibrinolytic significantly improves epicardial and myocardial infusion in comparison with the strategy of performing immediate intravenous thrombolysis (tenecteplase plus enoxaparine) followed by coronary angiography and adequate revascularization.


Options:
A: Arm Label: XIENCE V®; Type: EXPERIMENTAL; Interventions: Device: XIENCE V® Everolimus Eluting Coronary Stent | Arm Label: TAXUS™ EXPRESS2™; Type: ACTIVE_COMPARATOR; Interventions: Device: TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent | Intervention Type: DEVICE; Name: XIENCE V® Everolimus Eluting Coronary Stent; Assigned to Arm(s): XIENCE V® | Intervention Type: DEVICE; Name: TAXUS™ EXPRESS2™ Paclitaxel Eluting Coronary Stent; Assigned to Arm(s): TAXUS™ EXPRESS2™
B: Arm Label: 1. Resolute; Type: ACTIVE_COMPARATOR; Interventions: Device: Medtronic Endeavor Resolute | Arm Label: 2. XIENCE V; Type: ACTIVE_COMPARATOR; Interventions: Device: Abbott Xience V | Intervention Type: DEVICE; Name: Medtronic Endeavor Resolute; Assigned to Arm(s): 1. Resolute | Intervention Type: DEVICE; Name: Abbott Xience V; Assigned to Arm(s): 2. XIENCE V
C: Arm Label: bare-metal stent without tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Arm Label: bare-metal stent with tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Arm Label: paclitaxel-eluting stent without tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Arm Label: paclitaxel-eluting stent with tirofiban; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Postfibrinolysis percutaneous coronary intervention | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): bare-metal stent without tirofiban | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): bare-metal stent with tirofiban | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): paclitaxel-eluting stent without tirofiban | Intervention Type: PROCEDURE; Name: Postfibrinolysis percutaneous coronary intervention; Assigned to Arm(s): paclitaxel-eluting stent with tirofiban
D: Intervention Type: DRUG; Name: Angiomax (bivalirudin) anticoagulant; Assigned to Arm(s): N/A

Answer: C